Welcome to our dedicated page for Finnovate Acquisition news (Ticker: FNVT), a resource for investors and traders seeking the latest updates and insights on Finnovate Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Finnovate Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Finnovate Acquisition's position in the market.
Finnovate Acquisition Corp (Nasdaq: FNVT, FNVTU, FNVTW) announced changes to its upcoming extraordinary general meeting and sponsor contributions. The Sponsor will contribute $0.05 per unredeemed Class A ordinary share monthly from November 8, 2024, to May 8, 2025, to support the extension period for completing an initial business combination. If extended to May 2025, this would increase the redemption amount to approximately $11.91 per unredeemed share, up from the current $11.61. The Special Meeting has been postponed to November 6, 2024, at 10:00 AM ET, with a new redemption deadline of November 4, 2024, at 5:00 PM ET.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Finnovate Acquisition (FNVT)?
What is the market cap of Finnovate Acquisition (FNVT)?
